Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea
· Delayed Price · Currency is KRW 131,400
+1,300 (1.00%)
At close: Apr 18, 2025, 3:30 PM KST
Daewoong Pharmaceutical Revenue
In the year 2024, Daewoong Pharmaceutical had annual revenue of 1.42T KRW with 3.44% growth. Daewoong Pharmaceutical had revenue of 367.88B in the quarter ending December 31, 2024, with 1.67% growth.
Revenue
1,422.68B
Revenue Growth
+3.44%
P/S Ratio
1.06
Revenue / Employee
823.79M
Employees
1,727
Market Cap
1,513.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,422.68B | 47.35B | 3.44% |
| Dec 31, 2023 | 1,375.33B | 95.24B | 7.44% |
| Dec 31, 2022 | 1,280.09B | 127.12B | 11.03% |
| Dec 31, 2021 | 1,152.98B | 97.55B | 9.24% |
| Dec 31, 2020 | 1,055.42B | -58.00B | -5.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |